Literature DB >> 10828880

Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.

M Firon1, M Shaharabany, R T Altstock, J Horev, A Abramovici, J H Resau, G F Vande Woude, I Tsarfaty.   

Abstract

Activation of the Met tyrosine kinase growth factor receptor by its ligand HGF/SF has been shown to increase in vitro invasiveness in epithelial cell lines. To study the effect of Met-HGF/SF signaling in breast cancer cells, we transfected met, hgf/sf and dominant negative (DN) forms of met into the poorly differentiated metastatic murine mammary adenocarcinoma cell line DA3. These cells express moderate levels of endogenous Met, which is rapidly phosphorylated in response to HGF/SF treatment. Met+hgf/sf transfection results in significantly increased tumorigenic and metastatic activity in vivo accompanied by reduced tubule formation. DA3 cells transfected with DN forms of Met (DN-DA3) exhibit reduced Met phosphorylation following exposure to HGF/SF. Furthermore, as compared to the parental cells, the DN-DA3 cells exhibit diminished in vitro scattering and invasiveness, while in vivo they display greatly reduced tumorigenicity and spontaneous metastasis. Tumors emanating from DN-DA3 cells injected to BALB/C mice are highly differentiated and display extensive tubule formation. These results suggest that Met-HGF/SF signaling is a determining factor in the delicate balance between differentiation/tubule formation and tumorigenicity-metastasis. Oncogene (2000) 19, 2386 - 2397

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828880     DOI: 10.1038/sj.onc.1203557

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Secrets of tubule engineering by epithelial cells.

Authors:  Ilan Tsarfaty; Eshel Ben-Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

2.  Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.

Authors:  Gregory A Watson; Xinglu Zhang; Michael T Stang; Ryan M Levy; Pierre E Queiroz de Oliveira; William E Gooding; James G Christensen; Steven J Hughes
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

3.  HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met.

Authors:  Galia Tsarfaty; Gideon Y Stein; Sharon Moshitch-Moshkovitz; Dafna W Kaufman; Brain Cao; James H Resau; George F Vande Woude; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

4.  Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization.

Authors:  Gil M Yerushalmi; Raya Leibowitz-Amit; Miriam Shaharabany; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

5.  Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase.

Authors:  K A Furge; D Kiewlich; P Le; M N Vo; M Faure; A R Howlett; K E Lipson; G F Vande Woude; C P Webb
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

6.  Association of activated c-Met with NRAS-mutated human melanomas.

Authors:  Chandrani Chattopadhyay; Julie A Ellerhorst; Suhendan Ekmekcioglu; Victoria R Greene; Michael A Davies; Elizabeth A Grimm
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

7.  Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer.

Authors:  Mevlude Inanc; Metin Ozkan; Halit Karaca; Veli Berk; Oktay Bozkurt; Ayse Ocak Duran; Ersin Ozaslan; Hulya Akgun; Fatos Tekelioglu; Ferhan Elmali
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

8.  Emergence of HGF/SF-induced coordinated cellular motility.

Authors:  Assaf Zaritsky; Sari Natan; Eshel Ben-Jacob; Ilan Tsarfaty
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

Review 9.  Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis.

Authors:  J W Pollard
Journal:  Breast Cancer Res       Date:  2001-06-14       Impact factor: 6.466

10.  Live time-lapse dataset of in vitro wound healing experiments.

Authors:  Assaf Zaritsky; Sari Natan; Doron Kaplan; Eshel Ben-Jacob; Ilan Tsarfaty
Journal:  Gigascience       Date:  2015-02-25       Impact factor: 6.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.